Haleos Labs Updates Contact Email ID and Website Post Name Change
Haleos Labs Limited has updated its official contact email IDs to info@haleoslabs.com and cs@haleoslabs.com, and its website to www.haleoslabs.com. These changes follow the company's name change from SMS Lifesciences India Limited.
The change in email IDs and website is an administrative update following a name change and is unlikely to have a significant impact on the company's operations or stock performance.
The announcement pertains to an administrative update regarding the company's contact information and name change, with no immediate financial or operational impact indicated.
Haleos Labs Limited (formerly SMS Lifesciences India Limited) has updated its official contact email IDs and website. The new email addresses are info@haleoslabs.com and cs@haleoslabs.com, and the official website is now www.haleoslabs.com. These changes are a consequence of the company's name change. The company also informed its physical shareholders about these updates on March 30, 2026. The company's Corporate Identification Number (CIN) and other legal identities remain unchanged.
What to do with a filing like this
HALEOS LABS LIMITED filed this with the NSE as a statutory disclosure, categorised under other company updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by HALEOS LABS LIMITED. Read the original for the full detail.